Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidar Sharafi

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
BMC Gastroenterology|November 25, 2021
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsZahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, et al.
Virology Journal|October 8, 2021
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disordersHeidar Sharafi, Bita Behnava, Alireza Azizi-Saraji, et al.
Caspian Journal of Internal Medicine|February 12, 2020
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort studyHeidar Sharafi, Seyed Hoda Alavian, Bita Behnava, et al.
Archives of Virology|July 4, 2020
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysisRoya Rashti, Seyed Moayed Alavian, Yousef Moradi, et al.
Hepatitis Monthly|May 6, 2016
The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis CMohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, et al.
Hepatitis Monthly|May 3, 2012
Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment ResponseHeidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, et al.
Hepatitis Monthly|April 4, 2013
Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy IndividualsHeidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, et al.
Journal of Clinical Laboratory Analysis|April 17, 2018
A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphismsSeyed Ehsan Alavian, Heidar Sharafi, Paniz Shirmast, et al.
Hepatitis Monthly|March 6, 2015
Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based TherapySaleh Sandoughdaran, Seyed Moayed Alavian, Heidar Sharafi, et al.
Hepatitis Monthly|April 26, 2016
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, IranKhashayar Hesamizadeh, Heidar Sharafi, Hossein Keyvani, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
BMC Gastroenterology|November 25, 2021
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsZahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, et al.
Virology Journal|October 8, 2021
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disordersHeidar Sharafi, Bita Behnava, Alireza Azizi-Saraji, et al.
Caspian Journal of Internal Medicine|February 12, 2020
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort studyHeidar Sharafi, Seyed Hoda Alavian, Bita Behnava, et al.
Archives of Virology|July 4, 2020
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysisRoya Rashti, Seyed Moayed Alavian, Yousef Moradi, et al.
Hepatitis Monthly|May 6, 2016
The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis CMohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, et al.
Hepatitis Monthly|May 3, 2012
Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment ResponseHeidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, et al.
Hepatitis Monthly|April 4, 2013
Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy IndividualsHeidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, et al.
Journal of Clinical Laboratory Analysis|April 17, 2018
A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphismsSeyed Ehsan Alavian, Heidar Sharafi, Paniz Shirmast, et al.
Hepatitis Monthly|March 6, 2015
Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based TherapySaleh Sandoughdaran, Seyed Moayed Alavian, Heidar Sharafi, et al.
Hepatitis Monthly|April 26, 2016
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, IranKhashayar Hesamizadeh, Heidar Sharafi, Hossein Keyvani, et al.
Pageof 7